Dog /

Breed profile · FDA CVM July 2026 extract

Pointing Dog - Hungarian Short-haired (Vizsla) adverse-event record

Adverse-event filings for Pointing Dog - Hungarian Short-haired (Vizsla) (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

Verify with FDA CVM →
#89 of 510
by report volume (all breeds)
1,526
FDA CVM reports on file
4.3%
death-coded share of reports
#165 of 275
by death-coded share (≥50 reports)

How the 1,526 reports break down

By recorded gender -- every report on file for Pointing Dog - Hungarian Short-haired (Vizsla), no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 134 100.5 67 33.5 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Pointing Dog - Hungarian Short-haired (Vizsla) drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Pointing Dog - Hungarian Short-haired (Vizsla) ranks #89 of 510 by total reports (1,526) and #165 of 275 by death-coded share (4.3%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#89
This breed, reports of 510
#165
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Pointing Dog - Hungarian Short-haired (Vizsla) has 1,526 reports now versus 1,499 in that prior snapshot: 27 more (1.8%).

Report change
+27
Death-coded reports
+4
Death-coded share
+0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Pointing Dog - Hungarian Short-haired (Vizsla) changes

Total Reports

1,526

High report volume

Deaths Reported

65

of 1,526 reports

Death-coded share of reports

4.3%

Below-median death-coded share

Avg Age at Report

4.7 yr

23.0 kg avg weight

Breed Safety Scorecard

D (47/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate C
4.3%

Share of reports coded as a fatality

Euthanasia rate D
2.3%

Share of reports resulting in euthanasia

Full recovery rate D
28.5%

Share of reports coded "Recovered/Normal"

5-year trend F
+32%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Pointing Dog - Hungarian Short-haired (Vizsla) death-coded reports 4.3%
Cross-breed median

4.3% of 1,526 pointing dog - hungarian short-haired (vizsla) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Pointing Dog - Hungarian Short-haired (Vizsla)'s death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 40th percentile Higher share than 40% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Pointing Dog - Hungarian Short-haired (Vizsla) 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 23.0 kg (50.7 lbs)

Top Reported Reactions

Vomiting 296
Lack of efficacy (endoparasite) - hookworm 122
Diarrhoea 111
Lethargy (see also Central nervous system depression in 'Neurological') 99
Emesis 88
Lack of efficacy (endoparasite) - heartworm 88
Digestive tract disorder NOS 78
Lack of efficacy - NOS 73
Seizure NOS 73
INEFFECTIVE, ASCARIDS NOS 48
Lack of efficacy (endoparasite) - roundworm NOS 47
INEFFECTIVE, HOOKS 46
Other abnormal test result NOS 43
Anorexia 42
Death by euthanasia 37

Most Referenced Drugs

Milbemycin Oxime + Spinosad 237
Ivermectin + Pyrantel As Pamoate Salt 211
Afoxolaner 120
Pyrantel Pamoate;Sarolaner 100
Milbemycin Oxime + Praziquantel 84
Moxidectin 76
Fluralaner Chew Tablets 65
Oclacitinib Maleate 60
Carprofen 56
Bedinvetmab 45
Spinosad 43
Sarolaner 40
Fluralaner 13.64% 12-Week Chew 37
Maropitant Citrate 32
Trilostane 29

Outcome Breakdown

Outcome Unknown
496 (34.5%)
Recovered/Normal
435 (30.3%)
Ongoing
403 (28.0%)
Recovered with Sequela
39 (2.7%)
Euthanized
35 (2.4%)
Died
30 (2.1%)

Gender Distribution

Male 765 (50.1%)
Female 739 (48.4%)
Unknown 18 (1.2%)
Mixed 4 (0.3%)

Reports by Year

Year Reports Trend
2010 43
2011 56
2012 67
2013 67
2014 89
2015 102
2016 108
2017 112
2018 122
2019 108
2020 116
2021 85
2022 82
2023 103
2024 134
2025 112
2026 20

Pointing Dog - Hungarian Short-haired (Vizsla): high-volume FDA adverse-event cohort

Signature read: 1,526 reports place Pointing Dog - Hungarian Short-haired (Vizsla) in the upper third of breed filing volume (#89 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Pointing Dog - Hungarian Short-haired (Vizsla) sits at #89 of 510 by report volume among all breeds and #74 of 298 among dog breeds, with 1,526 reports and 65 (4.3%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #165 of 275. Mean age at report: 4.7 years, average weight 23.0 kg (50.7 lbs).

Top reported signs: Vomiting (296), Lack of efficacy (endoparasite) - hookworm (122), Diarrhoea (111). Most-referenced drug: Milbemycin Oxime + Spinosad (237 reports), followed by Ivermectin + Pyrantel As Pamoate Salt (211) and Afoxolaner (120).

Outcome coding on 1,438 status-recorded reports is dominated by Outcome Unknown (34.5%). Annual submissions ranged 20-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Terrier - Scottish
1,489 reports · 5.8% death-coded
Pointer (unspecified)
1,595 reports · 2.7% death-coded
Corgi - Welsh Pembroke
1,624 reports · 4.2% death-coded
Terrier - Irish Soft-coated Wheaten
1,654 reports · 3.3% death-coded
American Pit Bull Terrier
1,392 reports · 7.0% death-coded
Shiba Inu
1,673 reports · 2.5% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Pointing Dog - Hungarian Short-haired (Vizsla) drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (4.3% death-coded here).

Siberian 4.2% · Cat Bengal 4.6% · Cat British cat 3.8% · Cat Scottish Fold Longhair 4.8% · Cat

Similar average weight

Nearest other-species breeds by reported average weight (23.0 kg here).

Crossbred Caprine/goat 21.7 kg · Goat Mixed (Sheep) 24.9 kg · Sheep Pygmy 20.3 kg · Goat Wild cat 14.5 kg · Cat

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Pointing Dog - Hungarian Short-haired (Vizsla)? ▼
There are 1,526 adverse event reports involving Pointing Dog - Hungarian Short-haired (Vizsla) in the FDA database, of which 65 were death-coded (4.3% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Pointing Dog - Hungarian Short-haired (Vizsla) ranks #89 of 510 by report volume among all breeds PlainBreed indexes (#74 of 298 among dog breeds).
Where does Pointing Dog - Hungarian Short-haired (Vizsla) sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Pointing Dog - Hungarian Short-haired (Vizsla) is #89 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #74 of 298. Among breeds with at least 50 reports, its death-coded share ranks #165 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Pointing Dog - Hungarian Short-haired (Vizsla)? ▼
The most commonly reported adverse reactions for Pointing Dog - Hungarian Short-haired (Vizsla) are Vomiting (296 reports), Lack of efficacy (endoparasite) - hookworm (122 reports), Diarrhoea (111 reports), Lethargy (see also Central nervous system depression in 'Neurological') (99 reports), Emesis (88 reports).
What drugs are most frequently associated with Pointing Dog - Hungarian Short-haired (Vizsla) adverse events? ▼
The drugs most frequently referenced in Pointing Dog - Hungarian Short-haired (Vizsla) adverse event reports are Milbemycin Oxime + Spinosad (237 reports), Ivermectin + Pyrantel As Pamoate Salt (211 reports), Afoxolaner (120 reports), Pyrantel Pamoate;Sarolaner (100 reports), Milbemycin Oxime + Praziquantel (84 reports).
What is the average age of Pointing Dog - Hungarian Short-haired (Vizsla) in adverse event reports? ▼
The average age of Pointing Dog - Hungarian Short-haired (Vizsla) at the time of adverse event reports is 4.7 years, with an average weight of 23.0 kg (50.7 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Pointing Dog - Hungarian Short-haired (Vizsla) (Dog), extract as of July 2026 extract. 1,526 reports · 65 death-coded (4.3% of reports, not a mortality rate) · #89 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →